953 related articles for article (PubMed ID: 23457958)
1. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
[TBL] [Abstract][Full Text] [Related]
2. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
4. Mathematical Model-Based Accelerated Development of Extended-release Metformin Hydrochloride Tablet Formulation.
Chen W; Desai D; Good D; Crison J; Timmins P; Paruchuri S; Wang J; Ha K
AAPS PharmSciTech; 2016 Aug; 17(4):1007-13. PubMed ID: 26729531
[TBL] [Abstract][Full Text] [Related]
5. Metformin extended release: metformin gastric retention, metformin GR, metformin XR.
Drugs R D; 2005; 6(5):316-9. PubMed ID: 16128603
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
Blonde L; Dailey GE; Jabbour SA; Reasner CA; Mills DJ
Curr Med Res Opin; 2004 Apr; 20(4):565-72. PubMed ID: 15119994
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence and safety evaluation of two preparations of metformin hydrochloride sustained-release tablets (Boke
Sun ML; Liu C; Bai HH; Wei YL; Zhang W; Liu HJ; Li YJ; Liu L; Wang Y; Tong YX; Gao Q; Liu QY; Wang X
Ann Med; 2022 Dec; 54(1):2626-2635. PubMed ID: 36135935
[TBL] [Abstract][Full Text] [Related]
8. Formulation and development of hydrodynamically balanced system for metformin: in vitro and in vivo evaluation.
Ali J; Arora S; Ahuja A; Babbar AK; Sharma RK; Khar RK; Baboota S
Eur J Pharm Biopharm; 2007 Aug; 67(1):196-201. PubMed ID: 17270409
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of venlafaxine hydrochloride.
Yadav K; Yadav D; Srivastava AK
Drug Dev Ind Pharm; 2013 Aug; 39(8):1197-206. PubMed ID: 22803761
[TBL] [Abstract][Full Text] [Related]
10. Gamma scintigraphic study of the hydrodynamically balanced matrix tablets of Metformin HCl in rabbits.
Razavi M; Karimian H; Yeong CH; Sarji SA; Chung LY; Nyamathulla S; Noordin MI
Drug Des Devel Ther; 2015; 9():3125-39. PubMed ID: 26124637
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
12. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
Timmins P; Donahue S; Meeker J; Marathe P
Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
[TBL] [Abstract][Full Text] [Related]
13. Development of polymer-bound fast-dissolving metformin buccal film with disintegrants.
Haque SE; Sheela A
Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):199-205. PubMed ID: 26491321
[TBL] [Abstract][Full Text] [Related]
14. Influence of water-soluble polymers on the in vitro performance of floating mucoadhesive tablets containing metformin.
Rajab M; Jouma M; Neubert RH; Dittgen M
Drug Dev Ind Pharm; 2014 Jul; 40(7):879-85. PubMed ID: 23607725
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
[TBL] [Abstract][Full Text] [Related]
16. Metformin extended release--DepoMed: metformin, metformin gastric retention, metformin GR.
Drugs R D; 2004; 5(4):231-3. PubMed ID: 15230631
[TBL] [Abstract][Full Text] [Related]
17. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
18. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
Baviskar D; Sharma R; Jain D
Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
[TBL] [Abstract][Full Text] [Related]
19. [Influence of polymer type on the physical properties and the release study of papaverine hydrochloride from tablets].
Kasperek R; Polski A; Sobótka-Polska K; Poleszak E
Polim Med; 2014; 44(1):5-12. PubMed ID: 24918651
[TBL] [Abstract][Full Text] [Related]
20. Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatin.
Oh JH; Eun Lee J; Jeong Kim Y; Oh TO; Han S; Jeon EK; Shin K; Kim DH; Hye Park C; Lee YJ
Drug Dev Ind Pharm; 2016; 42(2):340-9. PubMed ID: 26467296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
